Close Menu

Biopsy Troubles

A personalized medicine study has run into an unexpected issue: tumor biopsies that aren't good enough to undergo genetic analysis, Stat News reports.

Between 10 percent and 20 percent of the needle biopsies collected for the National Cancer Institute MATCH trial, which began in August, are of poor quality and contain few tumor cells, it adds.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of Idaho researchers model the scientific discovery process to examine the link between reproducibility and scientific truth.

A bill passed by a US House of Representatives appropriations subcommittee would give scientific agencies including the National Science Foundation boosts in funding.

Relocating USDA agencies outside of Washington, DC, may make them less effective, critics of the move tell NPR.

In PLOS this week: genes that help Borrelia burgdorferi survive in ticks, CiliaCarta collection of about 1,000 suspected cilia genes, and more.